Skip to main content

Table 2 Study objectives, outcomes, methods, and timeline

From: Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso

Study objectives

Outcomes

Methods

Timeline

1. To compare the delivery of IPTp-SP through the integrated strategy (ANC + SMC) with standard care (ANC)

The proportion of women who received at least 3 doses of IPTp-SP during pregnancy

• Household survey of women with a child < 12 months

• Baseline

• Endline

2. To assess the acceptability and feasibility of ANC + SMC delivery of IPTp-SP compared to standard care (ANC) among health providers, CHWs, and pregnant women and women with a child < 12 months

Major themes emerging through thematic analysis using a theory of acceptability (developed a priori)

• In-depth interviews

• Focus group discussions

• Endline

3. To assess the systems effectiveness of the integrated delivery of IPTp-SP

Cumulative systems effectiveness of IPTp-SP delivery at ANC + SMC

• ANC exit interview of ANC attendees

• Endline

4. To assess any increase or decrease in ANC uptake following the integrated ANC + SMC IPTp-SP delivery

The proportion of women with 4 + ANC visits during pregnancy

• Household surveys of women with a child < 12 months

• Routine data collection: individual facility data on ANC attendance

• Baseline

• Endline

• Throughout the trial

5. To assess any increase or decrease in SMC uptake following the integrated ANC + SMC IPTp-SP delivery

The proportion of children 3–59 months who received 4 doses of SMC

• Household surveys of mothers of children 3–59 months

• Baseline

• Endline

6. To estimate the number of malaria cases in both children and pregnant women over the course of the trial, by arm

Confirmed malaria

• incidence rates and malaria positivity (RDT + /RDT performed) ratios

• Routine data collection: individual facility data on malaria cases for pregnant women and children 3–59 months

• Throughout the trial

7. To estimate the number of poor birth outcomes in women over the course of the trial, by arm

• The proportion of women with miscarriage, stillbirth, low birth weight, or preterm birth

• Routine data collection: individual facility data on birth outcomes

• Throughout the trial

8. To assess care-seeking practices during COVID and the anticipated acceptability of the integrated strategy of ANC + SMC delivery of IPTp-SP

• Major themes emerging through thematic analysis using a theory of acceptability (developed a priori)

• In-depth interviews with healthcare providers

• Focus group discussions with women

• Baseline